Research and Development

Showing 15 posts of 9596 posts found.

covid_cell_1_20

Pharmafile.com’s weekly COVID-19 news round-up

January 6, 2021 Research and Development COVID-19, Vaccine

In the first week of 2021, the global COVID-19 vaccination race continues to dominate the news. The EU states have …
who_flag

WHO recommends against 12-week delay for COVID-19 vaccine doses

January 6, 2021 Research and Development COVID-19, Vaccine, WHO

The WHO has recommended against the UK’s plans to delay second doses of the COVID-19 vaccine by 12 weeks, saying …
european_commission_web

Biogen’s IM Plegridy gets EU approval

January 6, 2021 Research and Development Biogen, multiple sclerosis

The European Commission has approved Biogen’s Plegridy (peginterferon beta-1a), a new intramuscular (IM) injection for the treatment of relapsing-remitting multiple …
angelini_pharma

Angelini Pharma to acquire Arvelle Therapeutics in $960 million deal

January 6, 2021 Research and Development Angelini Pharma, central nervous system

Angelini Pharma is set to acquire Arvelle Therapeutics, a biopharmaceutical company focused on bringing innovative treatments to patients suffering from …
astrazeneca_sign_sky

AstraZeneca’s Farxiga granted Priority Review by FDA

January 6, 2021 Research and Development AstraZeneca, FDA, farxiga

AstraZeneca’s Farxiga (dapagliflozin) has been granted Priority Review in the US for the treatment of new or worsening chronic kidney …
herbert

Clinigen appoints Sam Herbert as Chief Operating Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinigen, the global pharmaceutical and services company, has appointed Sam Herbert as Chief Operating Officer with immediate effect.
screenshot_2021-01-05_puretech_announces_the_appointment_of_george_farmer_ph_d__as_chief_financial_officer_biospace

PureTech appoints George Farmer as Chief Financial Officer

January 5, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

PureTech Health, a clinical-stage biotherapeutics company focused on highly differentiated medicines for devastating diseases, has appointed Dr George Farmer as …
top_10_image_2_1_5

Pharmafile.com’s top 10 stories of 2020

December 23, 2020 Research and Development

The COVID-19 pandemic has, unsurprisingly, dominated the news this year. The site’s most popular articles of 2020, focused largely on …

BioInvent receives $3m payment for antibodies selected by Pfizer

December 23, 2020 Research and Development BioInvent, Cancer, Pfizer

BioInvent International, a biotech company focused on the discovery and development of novel and first-in-class immune-modulatory antibodies for cancer immunotherapy, …
european_commission_web

Zogenix gets EU marketing authorisation for anti-seizure drug

December 23, 2020 Research and Development

The European Commission (EC) has granted marketing authorisation for Zogenix’s FINTEPLA (fenfluramine), an oral solution for the treatment of seizures …
covid_cell_1

Pharmafile.com’s weekly COVID-19 news round-up

December 23, 2020 Research and Development COVID-19, Vaccine

The United States’ mission to inoculate its population is well underway this week; not only has the FDA given emergency …

Vicore Pharma study suggests C21 could complement COVID-19 vaccines

December 23, 2020 Research and Development COVID-19, Vicore Pharma

Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …
1517679969844

Novavax appoints Rick Crowley as Executive Vice President, Chief Operations Officer.

December 22, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Novavax, a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, has announced the appointment of Rick Crowley to …

The importance of ethics and patient centricity in managed and early access programmes

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Matt Fellows explores how early and managed access schemes are mutually beneficial to sponsors and patients alike, as well as how …
1516998199715

4BIO Capital appoints Akiko Iwasaki to its Scientific Advisory Board

December 21, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

4BIO Capital, an international venture capital firm focused on advanced therapies addressing high unmet medical and social needs, has appointed …
The Gateway to Local Adoption Series

Latest content